Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Market recap successful trader vs verb bhi. Dow -582-3% nasdaq-.27% VERB 1.05-3.7%. TRADER HTZ +30%,ERI$10+18%, ZM$160 +22%,TXRH$39 +10%. Despite the dow being down almost 600pts the nimble trader manages to secure hefty gains while the verb bhi can only dream of higher stock prices next qtr or the one after that.
Whwn the free money gets paid out where do u think a portion of the population will go and spend it? Casinos ERI $9s fell from $60s to $6s. When the Corona bucks go out the casinos will manage to open their doors. Gambling is an addiction for some they will blow the entire gov payment on slots. Rebound coming
If the guys diluting this would get lockeddown then the stock would run everytime they put out news. Im getting tired of watching the morons dump shares as soon as the prs go out. Stock pops then slammed with dumping that takes it below the previous close. 4 prs in a row same ole shxx. I hate Fing diluted stocks. Management better get this fixed or Im going to turn into a basher from HELL!
Nope not true car and htz both moving higher rental car demand is going to surge higher. Just wait till they close down the airlines you wo t be able to find a rental car. Even if they dont so u want to ride in a NYC cab or sfc uber who knows how many sickos say in that back seat coughing up their Corona lungs
Not true zm doing well. Rental car companies htz car being accumulated for when the airline s are grounded, imagine being at the airport when that happens. Plus anyone want to take a taxi or uber for the foreseeable future, until it's been sprayed with tomz Corona killer
ZM 159.49 high today up $28, up $59 since my son recommended it at $100 just over a week ago. -He looked at verb months ago, he said "not impressed. Google YouTube annotations basicly a RIP off YouTube annotations that were retired 2017 because they were a outdated. He said they were annoying and he would shut them off" Rory is all about flash not function especially practical function. He is a name dropper his bod are just names meant to impress seems to be working on some individuals. Verb down again in the same period ZM leader is running away. While most students graduate college with huge debt my son is decades ahead with a mountain of cash. He's been learning about the stock market since he was 2.
TOMZ CORONA KILLER NEWS!
STERAMIST UTILIZED BY CVS PHARMACY IN RESPONSE TO CORONAVIRUS
GlobeNewswire GlobeNewswireMarch 23, 2020
BEVERLY HILLS, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). CVS Pharmacy utilizes SteraMist disinfection in cleaning protocols as a response to the possibility of SARS CoV-2 coronavirus exposure.
The CVS Health Enterprise Response and Resiliency and Infectious Disease Response teams are closely monitoring the coronavirus outbreak. CVS follows cleaning protocols as suggested by the Centers for Disease Control (CDC) general cleaning guidelines and implements SteraMist in their cleaning practices. CVS released a FAQ article, “What you need to know about the coronavirus (COVID-19),” announcing procedures they have in place to ensure health and safety of their customers, patients, and employees which includes the use of SteraMist, an EPA registered disinfectant with efficacy against SARS CoV-2 coronavirus - EPA List N.
CVS gives guidance on the following question, “What cleaning practices does CVS undertake when there is a confirmed case or exposure situation?” CVS responded, “A deep cleaning will be performed, which consists of wiping down all horizontal and high contact touch points and using….SteraMist spray.”
TOMI’s CEO, Dr. Halden Shane, states, “I am not totally surprised about the contagiousness of this new SARS CoV-2, coronavirus pandemic. Also, what is not surprising to me is the fact that this pandemic has changed infectious disease protocols forever as businesses adopt SteraMist into their routine and emergency response protocols. In these uncertain times, TOMI will continue to provide our technology around the world to aid in reducing the spread of SARS CoV-2.”
Please refer to CVS Pharmacy’s website for additional information: https://www.cvs.com/content/coronavirus
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
[img]http://investorshub.advfn.com/uimage/uploads/2020/3/23/llkkmtomz5.jpeg[/
TOMZ CORONA KILLER NEWS!
STERAMIST UTILIZED BY CVS PHARMACY IN RESPONSE TO CORONAVIRUS
GlobeNewswire GlobeNewswireMarch 23, 2020
BEVERLY HILLS, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). CVS Pharmacy utilizes SteraMist disinfection in cleaning protocols as a response to the possibility of SARS CoV-2 coronavirus exposure.
The CVS Health Enterprise Response and Resiliency and Infectious Disease Response teams are closely monitoring the coronavirus outbreak. CVS follows cleaning protocols as suggested by the Centers for Disease Control (CDC) general cleaning guidelines and implements SteraMist in their cleaning practices. CVS released a FAQ article, “What you need to know about the coronavirus (COVID-19),” announcing procedures they have in place to ensure health and safety of their customers, patients, and employees which includes the use of SteraMist, an EPA registered disinfectant with efficacy against SARS CoV-2 coronavirus - EPA List N.
CVS gives guidance on the following question, “What cleaning practices does CVS undertake when there is a confirmed case or exposure situation?” CVS responded, “A deep cleaning will be performed, which consists of wiping down all horizontal and high contact touch points and using….SteraMist spray.”
TOMI’s CEO, Dr. Halden Shane, states, “I am not totally surprised about the contagiousness of this new SARS CoV-2, coronavirus pandemic. Also, what is not surprising to me is the fact that this pandemic has changed infectious disease protocols forever as businesses adopt SteraMist into their routine and emergency response protocols. In these uncertain times, TOMI will continue to provide our technology around the world to aid in reducing the spread of SARS CoV-2.”
Please refer to CVS Pharmacy’s website for additional information: https://www.cvs.com/content/coronavirus
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
[img]http://investorshub.advfn.com/uimage/uploads/2020/3/23/llkkmtomz5.jpeg[/
TOMZ CORONA KILLER NEWS!
STERAMIST UTILIZED BY CVS PHARMACY IN RESPONSE TO CORONAVIRUS
GlobeNewswire GlobeNewswireMarch 23, 2020
BEVERLY HILLS, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). CVS Pharmacy utilizes SteraMist disinfection in cleaning protocols as a response to the possibility of SARS CoV-2 coronavirus exposure.
The CVS Health Enterprise Response and Resiliency and Infectious Disease Response teams are closely monitoring the coronavirus outbreak. CVS follows cleaning protocols as suggested by the Centers for Disease Control (CDC) general cleaning guidelines and implements SteraMist in their cleaning practices. CVS released a FAQ article, “What you need to know about the coronavirus (COVID-19),” announcing procedures they have in place to ensure health and safety of their customers, patients, and employees which includes the use of SteraMist, an EPA registered disinfectant with efficacy against SARS CoV-2 coronavirus - EPA List N.
CVS gives guidance on the following question, “What cleaning practices does CVS undertake when there is a confirmed case or exposure situation?” CVS responded, “A deep cleaning will be performed, which consists of wiping down all horizontal and high contact touch points and using….SteraMist spray.”
TOMI’s CEO, Dr. Halden Shane, states, “I am not totally surprised about the contagiousness of this new SARS CoV-2, coronavirus pandemic. Also, what is not surprising to me is the fact that this pandemic has changed infectious disease protocols forever as businesses adopt SteraMist into their routine and emergency response protocols. In these uncertain times, TOMI will continue to provide our technology around the world to aid in reducing the spread of SARS CoV-2.”
Please refer to CVS Pharmacy’s website for additional information: https://www.cvs.com/content/coronavirus
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
UAE GROUNDED ALL FLIGHTS it coming to a country near you. RENTAL CAR DEMAND IS GOING TO SKYROCKET.
NG $1.53 New lows, as predicted
Zm is/has already been in use at most colleges for online classes lectures. Both my kids are in college and Zm is what their using. I mentioned this several days ago. Colleges are not going to switch and start using verbs faulty widget. Students would be demanding money back when verbs widget didn't work. I alerted Zm when it was 105 now 130. Likely it will continue higher. Thank my son he's the one that told me. He also mentioned aprn at $2 as a candidate to run when people have to stay home. Smart kid he but didn't say anything about verb. Maybe rory will put out a pr about launching a interactive school online learning widget. Might get a pop when the bhs get excited and buy more brand spanking new dilution shares. There is so many different trading opportunities in the market right now.
If the airlines become grounded what do u suppose all the stranded passengers will do. Run for the nearest car rental counter. A possible scenario. Htz,Car both good buys this week
TOMZ CORONA KILLER IN NEWS! VIDEO
https://www.cbs42.com/news/health/coronavirus/pelham-company-targets-coronavirus-with-new-cleaning-service/
TOMZ CORONA KILLER NEWS VIDEO
https://13wham.com/news/local/local-company-using-steramist-technology-to-disinfect-homes-from-coronavirus
TOMZ CORONA KILLER NEWS! TOMI’S EXCLUSIVE PARTNER CLEAN-BIT EXPANDS STERAMIST THROUGHOUT ISRAEL
GlobeNewswire GlobeNewswireMarch 19, 2020
BEVERLY HILLS, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). TOMI’s exclusive partner in Israel, Clean-Bit, expands their SteraMist disinfection services.
TOMI entered into an exclusive agreement with Clean-Bit for use of SteraMist throughout Israel. Clean-Bit has bought over 1.6 million dollars to date of TOMI technology and Solution for use in Israel. Clean-Bit is the official Israeli company for decontamination in Israel.
At the forefront of combating SARS CoV-2 coronavirus, Clean-Bit secured both government contracts - including the Ministry of Defense - and private contracts for SteraMist disinfection to be used in hospitals, restaurants, grocery stores, food stores, ambulances and other transportation, including aircraft.
Yaki Agam, CEO of Clean-Bit, TOMI’s partner in Israel, says “Clean-Bit has developed its own 'virus fighting bible' and is preventing the spread of the SARS CoV-2 coronavirus throughout the entire state of Israel. We have gained tremendous experience and success on the ground, utilizing TOMI’s SteraMist biological capabilities, while servicing and preventing the spread of the virus in all of Israel’s hospitals and defense facilities. The combination of our multi-disciplinary proprietary protocols combined with SteraMist technology, is an unbeatable formula.
We are thrilled to have our protocols now adopted throughout all of Israel. Thus, Clean-Bit has decided to open offices in other counties, utilizing its proprietary protocols and the cutting edge SteraMist technology to address all biological threats and stop the global spread of SARS CoV-2 coronavirus as well as other contamination threats.”
TOMI’s CEO, Dr. Halden Shane, states, “With the spread of SARS CoV-2 throughout the world, it is significant that no touch disinfection and decontamination is added to older manual cleaning protocols and is used to combat this deadly virus and assisting the world in flattening the curse of progression as well as controlling other pathogens which we cannot forget. We are here to assist our customers and continue to innovate for a safer world.”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit http://www.tomimist.com/ or
contact us at info@tomimist.com.
TOMZ CORONA KILLER NEWS! TOMI’S EXCLUSIVE PARTNER CLEAN-BIT EXPANDS STERAMIST THROUGHOUT ISRAEL
GlobeNewswire GlobeNewswireMarch 19, 2020
BEVERLY HILLS, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). TOMI’s exclusive partner in Israel, Clean-Bit, expands their SteraMist disinfection services.
TOMI entered into an exclusive agreement with Clean-Bit for use of SteraMist throughout Israel. Clean-Bit has bought over 1.6 million dollars to date of TOMI technology and Solution for use in Israel. Clean-Bit is the official Israeli company for decontamination in Israel.
At the forefront of combating SARS CoV-2 coronavirus, Clean-Bit secured both government contracts - including the Ministry of Defense - and private contracts for SteraMist disinfection to be used in hospitals, restaurants, grocery stores, food stores, ambulances and other transportation, including aircraft.
Yaki Agam, CEO of Clean-Bit, TOMI’s partner in Israel, says “Clean-Bit has developed its own 'virus fighting bible' and is preventing the spread of the SARS CoV-2 coronavirus throughout the entire state of Israel. We have gained tremendous experience and success on the ground, utilizing TOMI’s SteraMist biological capabilities, while servicing and preventing the spread of the virus in all of Israel’s hospitals and defense facilities. The combination of our multi-disciplinary proprietary protocols combined with SteraMist technology, is an unbeatable formula.
We are thrilled to have our protocols now adopted throughout all of Israel. Thus, Clean-Bit has decided to open offices in other counties, utilizing its proprietary protocols and the cutting edge SteraMist technology to address all biological threats and stop the global spread of SARS CoV-2 coronavirus as well as other contamination threats.”
TOMI’s CEO, Dr. Halden Shane, states, “With the spread of SARS CoV-2 throughout the world, it is significant that no touch disinfection and decontamination is added to older manual cleaning protocols and is used to combat this deadly virus and assisting the world in flattening the curse of progression as well as controlling other pathogens which we cannot forget. We are here to assist our customers and continue to innovate for a safer world.”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit http://www.tomimist.com/ or
contact us at info@tomimist.com.
TOMZ CORONA KILLER NEWSTOMI’S EXCLUSIVE PARTNER CLEAN-BIT EXPANDS STERAMIST THROUGHOUT ISRAEL
GlobeNewswire GlobeNewswireMarch 19, 2020
BEVERLY HILLS, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (TOMZ), is a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products - a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP). TOMI’s exclusive partner in Israel, Clean-Bit, expands their SteraMist disinfection services.
TOMI entered into an exclusive agreement with Clean-Bit for use of SteraMist throughout Israel. Clean-Bit has bought over 1.6 million dollars to date of TOMI technology and Solution for use in Israel. Clean-Bit is the official Israeli company for decontamination in Israel.
At the forefront of combating SARS CoV-2 coronavirus, Clean-Bit secured both government contracts - including the Ministry of Defense - and private contracts for SteraMist disinfection to be used in hospitals, restaurants, grocery stores, food stores, ambulances and other transportation, including aircraft.
Yaki Agam, CEO of Clean-Bit, TOMI’s partner in Israel, says “Clean-Bit has developed its own 'virus fighting bible' and is preventing the spread of the SARS CoV-2 coronavirus throughout the entire state of Israel. We have gained tremendous experience and success on the ground, utilizing TOMI’s SteraMist biological capabilities, while servicing and preventing the spread of the virus in all of Israel’s hospitals and defense facilities. The combination of our multi-disciplinary proprietary protocols combined with SteraMist technology, is an unbeatable formula.
We are thrilled to have our protocols now adopted throughout all of Israel. Thus, Clean-Bit has decided to open offices in other counties, utilizing its proprietary protocols and the cutting edge SteraMist technology to address all biological threats and stop the global spread of SARS CoV-2 coronavirus as well as other contamination threats.”
TOMI’s CEO, Dr. Halden Shane, states, “With the spread of SARS CoV-2 throughout the world, it is significant that no touch disinfection and decontamination is added to older manual cleaning protocols and is used to combat this deadly virus and assisting the world in flattening the curse of progression as well as controlling other pathogens which we cannot forget. We are here to assist our customers and continue to innovate for a safer world.”
TOMI™ Environmental Solutions, Inc.: Innovating for a safer world®
TOMI™ Environmental Solutions, Inc. (OTCQB:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.
TOMI products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. TOMI products and services have also been used in single-family homes and multi-unit residences.
TOMI develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.
For additional information, please visit http://www.tomimist.com/ or
contact us at info@tomimist.com.
No I'm not i just explained why buying underlying companies which are so way oversold is better long term. Oilu is going away and uwt is unraveling.crudes up 1.7% uwt -.05%, oilu +5% mro+4.4% dnr+11%. Dnr moves like a leveraged ETF without the nonstop bleed. Mro is going to be a solid investment for a long term.the 3x etf/n in general are a good way to lose money long term unless u short them
I'm buying oil companies vs 3x garbage which constantly bleeds. I bought DNR .25 MRO $3.6s. Both track the price of crude closely. Mro was $14 in jan. The ceo just bought $191k of stock.this is buy n hold. Pays a 5.8% dividend. Dnr I flipped it twice last week.26 to .44 then .3 to.44. Right when the 3x long crude should be a stellar buy one of them decides to stop trading shows the underlying fundamentals are weak. In a yr or 2 MRO is likely to be u 4 to 5 fold.
Dont intervene just put a tariff on imported oil without addressing the source of oil. Then sit back and watch the problem go away. Then we have crude stable near $55. Now us energy companies can plan longer term. The price of gas would be about $2.5 per gallon.
History repeating itself Saudis dump the price of crude this time they say in response to Russia. Reality is they are doing it to put US oil companies out of business like they have done so many times before.
Time to change history forever or become energy dependent on the mideast. Simply put a tariff on all imported oil equivalent to $55 per barrel and keep it there 4EVER! Do that and the price of oil will support the US energy industry and the sandmen can go pound sand. Otherwise we become dependent on mideast oil again they raise the price go back to funding terrorist groups that kill more Americans. I worked the Oil boom in Rocky Mts in the early 80s saw the boom bust cycle and we are falling for the sameole stuff.
Crude up 23% today 3x oilu +46% 3x UWT +22%. Oilu broke 1 rubber and UWT has 2 broken rubberband, dirty cracked mirrors. Time for rs maintenance.
TXRH Just made new high for today $35.33 showing strength great company and stock at these prices
Sold txrh 34.51
Sold at open the rubber bands are unwinding
CYDY$1 HUGE NEWS!U.S. Food and Drug Administration (FDA) Grants Emergency IND for Two Coronavirus Patients Treated in New York with CytoDyn’s Leronlimab
GlobeNewswire GlobeNewswireMarch 19, 2020
A leading academic medical center has administered the test medication, leronlimab, in two of their sickest COVID-19 patients. Neither patient has had any serious adverse reactions to leronlimab since it was administered. We are hopeful leronlimab will provide help to severely ill COVID-19 patients.
VANCOUVER, Washington, March 19, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that two coronavirus patients were treated with the Company’s investigational new drug, leronlimab. The treatment was administered at a leading medical center in the New York City area under an emergency Investigational New Drug (IND) recently granted by the U.S. Food and Drug Administration (FDA). Leronlimab is intended to serve as a therapy for patients who experience respiratory illness as a result of contracting the Coronavirus Disease 2019 (COVID-19). The treatment of these patients was not under the Company’s proposed randomized controlled Phase 2 clinical trial protocol recently submitted to the FDA.
Bruce Patterson M.D., CEO of IncellDX and advisor to CytoDyn, added, “Leronlimab binds to the CCR5 receptor inhibiting the migration of macrophages and the release on inflammatory cytokines including TNF and IL-6. This release of cytokines is what is commonly referred to as the 'cytokine storm' and is believed to cause profound damage in the lungs in some patients. In addition, leronlimab can block Regulatory T cells (Tregs), which can inhibit the innate immune response against pathogens, into areas of inflammation. These combined mechanisms of action may reduce the morbidity and mortality in moderate to severe cases of COVID-19, preventing the acute respiratory distress syndrome associated with this highly destructive and potentially fatal disease.”
Nader Pourhassan, Ph.D., president and chief executive officer of CytoDyn said, “We are very pleased that we have a potential treatment option for patients affected by COVID-19 infection. To be very clear, leronlimab does not kill the novel coronavirus. It acts as a CCR5 antagonist by blocking pro-inflammatory cytokines, which prevents cytokine storm and thus could be useful in treatment of COVID-19. Leronlimab is administered as a once-a-week injection. It has a strong safety profile demonstrated in nine clinical trials with over 800 people and is available for urgent treatment. If results are promising, we have leronlimab available for immediate use and the ability to scale production. We are open and willing to work with government agencies and pharmaceutical partnerships to assist in serving those in dire need of a treatment option for this devastating disease. We appreciate the FDA’s prompt response and are working in full support of the treating medical team.”
About Coronavirus Disease 2019
The Coronavirus Disease 2019 (COVID-19) was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. The origin of COVID-19 is uncertain and it is unclear how easily the virus spreads. COVID-19 is thought to be transmitted person to person through respiratory droplets, commonly resulting from coughing, sneezing and close personal contact. Coronaviruses are a large family of viruses, some causing illness in people and others that circulate among animals. For confirmed COVID-19 infections, symptoms have included fever, cough and shortness of breath. It is believed that symptoms of COVID-19 may appear in as few as two days or as long as 14 days after exposure, and that symptoms in patients have ranged from non-existent to severe and fatal. At this time, there are very limited treatment options for COVID-19.
About Leronlimab (PRO 140)
The FDA has granted a “Fast Track” designation to CytoDyn for two potential indications of leronlimab for deadly diseases. The first as a combination therapy with HAART for HIV-infected patients, and the second is for metastatic triple-negative breast cancer. Leronlimab is an investigational humanized IgG4 mAb that blocks CCR5, a cellular receptor that is important in HIV infection, tumor metastases, and other diseases including NASH. Leronlimab has successfully completed nine clinical trials in over 800 people, including meeting its primary endpoints in a pivotal Phase 3 trial (leronlimab in combination with standard antiretroviral therapies in HIV-infected treatment-experienced patients).
CYDY$1 HUGE NEWS!U.S. Food and Drug Administration (FDA) Grants Emergency IND for Two Coronavirus Patients Treated in New York with CytoDyn’s Leronlimab
GlobeNewswire GlobeNewswireMarch 19, 2020
A leading academic medical center has administered the test medication, leronlimab, in two of their sickest COVID-19 patients. Neither patient has had any serious adverse reactions to leronlimab since it was administered. We are hopeful leronlimab will provide help to severely ill COVID-19 patients.
VANCOUVER, Washington, March 19, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that two coronavirus patients were treated with the Company’s investigational new drug, leronlimab. The treatment was administered at a leading medical center in the New York City area under an emergency Investigational New Drug (IND) recently granted by the U.S. Food and Drug Administration (FDA). Leronlimab is intended to serve as a therapy for patients who experience respiratory illness as a result of contracting the Coronavirus Disease 2019 (COVID-19). The treatment of these patients was not under the Company’s proposed randomized controlled Phase 2 clinical trial protocol recently submitted to the FDA.
Bruce Patterson M.D., CEO of IncellDX and advisor to CytoDyn, added, “Leronlimab binds to the CCR5 receptor inhibiting the migration of macrophages and the release on inflammatory cytokines including TNF and IL-6. This release of cytokines is what is commonly referred to as the 'cytokine storm' and is believed to cause profound damage in the lungs in some patients. In addition, leronlimab can block Regulatory T cells (Tregs), which can inhibit the innate immune response against pathogens, into areas of inflammation. These combined mechanisms of action may reduce the morbidity and mortality in moderate to severe cases of COVID-19, preventing the acute respiratory distress syndrome associated with this highly destructive and potentially fatal disease.”
Nader Pourhassan, Ph.D., president and chief executive officer of CytoDyn said, “We are very pleased that we have a potential treatment option for patients affected by COVID-19 infection. To be very clear, leronlimab does not kill the novel coronavirus. It acts as a CCR5 antagonist by blocking pro-inflammatory cytokines, which prevents cytokine storm and thus could be useful in treatment of COVID-19. Leronlimab is administered as a once-a-week injection. It has a strong safety profile demonstrated in nine clinical trials with over 800 people and is available for urgent treatment. If results are promising, we have leronlimab available for immediate use and the ability to scale production. We are open and willing to work with government agencies and pharmaceutical partnerships to assist in serving those in dire need of a treatment option for this devastating disease. We appreciate the FDA’s prompt response and are working in full support of the treating medical team.”
About Coronavirus Disease 2019
The Coronavirus Disease 2019 (COVID-19) was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. The origin of COVID-19 is uncertain and it is unclear how easily the virus spreads. COVID-19 is thought to be transmitted person to person through respiratory droplets, commonly resulting from coughing, sneezing and close personal contact. Coronaviruses are a large family of viruses, some causing illness in people and others that circulate among animals. For confirmed COVID-19 infections, symptoms have included fever, cough and shortness of breath. It is believed that symptoms of COVID-19 may appear in as few as two days or as long as 14 days after exposure, and that symptoms in patients have ranged from non-existent to severe and fatal. At this time, there are very limited treatment options for COVID-19.
About Leronlimab (PRO 140)
The FDA has granted a “Fast Track” designation to CytoDyn for two potential indications of leronlimab for deadly diseases. The first as a combination therapy with HAART for HIV-infected patients, and the second is for metastatic triple-negative breast cancer. Leronlimab is an investigational humanized IgG4 mAb that blocks CCR5, a cellular receptor that is important in HIV infection, tumor metastases, and other diseases including NASH. Leronlimab has successfully completed nine clinical trials in over 800 people, including meeting its primary endpoints in a pivotal Phase 3 trial (leronlimab in combination with standard antiretroviral therapies in HIV-infected treatment-experienced patients).
CYDY$1 HUGE NEWS!U.S. Food and Drug Administration (FDA) Grants Emergency IND for Two Coronavirus Patients Treated in New York with CytoDyn’s Leronlimab
GlobeNewswire GlobeNewswireMarch 19, 2020
A leading academic medical center has administered the test medication, leronlimab, in two of their sickest COVID-19 patients. Neither patient has had any serious adverse reactions to leronlimab since it was administered. We are hopeful leronlimab will provide help to severely ill COVID-19 patients.
VANCOUVER, Washington, March 19, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that two coronavirus patients were treated with the Company’s investigational new drug, leronlimab. The treatment was administered at a leading medical center in the New York City area under an emergency Investigational New Drug (IND) recently granted by the U.S. Food and Drug Administration (FDA). Leronlimab is intended to serve as a therapy for patients who experience respiratory illness as a result of contracting the Coronavirus Disease 2019 (COVID-19). The treatment of these patients was not under the Company’s proposed randomized controlled Phase 2 clinical trial protocol recently submitted to the FDA.
Bruce Patterson M.D., CEO of IncellDX and advisor to CytoDyn, added, “Leronlimab binds to the CCR5 receptor inhibiting the migration of macrophages and the release on inflammatory cytokines including TNF and IL-6. This release of cytokines is what is commonly referred to as the 'cytokine storm' and is believed to cause profound damage in the lungs in some patients. In addition, leronlimab can block Regulatory T cells (Tregs), which can inhibit the innate immune response against pathogens, into areas of inflammation. These combined mechanisms of action may reduce the morbidity and mortality in moderate to severe cases of COVID-19, preventing the acute respiratory distress syndrome associated with this highly destructive and potentially fatal disease.”
Nader Pourhassan, Ph.D., president and chief executive officer of CytoDyn said, “We are very pleased that we have a potential treatment option for patients affected by COVID-19 infection. To be very clear, leronlimab does not kill the novel coronavirus. It acts as a CCR5 antagonist by blocking pro-inflammatory cytokines, which prevents cytokine storm and thus could be useful in treatment of COVID-19. Leronlimab is administered as a once-a-week injection. It has a strong safety profile demonstrated in nine clinical trials with over 800 people and is available for urgent treatment. If results are promising, we have leronlimab available for immediate use and the ability to scale production. We are open and willing to work with government agencies and pharmaceutical partnerships to assist in serving those in dire need of a treatment option for this devastating disease. We appreciate the FDA’s prompt response and are working in full support of the treating medical team.”
About Coronavirus Disease 2019
The Coronavirus Disease 2019 (COVID-19) was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. The origin of COVID-19 is uncertain and it is unclear how easily the virus spreads. COVID-19 is thought to be transmitted person to person through respiratory droplets, commonly resulting from coughing, sneezing and close personal contact. Coronaviruses are a large family of viruses, some causing illness in people and others that circulate among animals. For confirmed COVID-19 infections, symptoms have included fever, cough and shortness of breath. It is believed that symptoms of COVID-19 may appear in as few as two days or as long as 14 days after exposure, and that symptoms in patients have ranged from non-existent to severe and fatal. At this time, there are very limited treatment options for COVID-19.
About Leronlimab (PRO 140)
The FDA has granted a “Fast Track” designation to CytoDyn for two potential indications of leronlimab for deadly diseases. The first as a combination therapy with HAART for HIV-infected patients, and the second is for metastatic triple-negative breast cancer. Leronlimab is an investigational humanized IgG4 mAb that blocks CCR5, a cellular receptor that is important in HIV infection, tumor metastases, and other diseases including NASH. Leronlimab has successfully completed nine clinical trials in over 800 people, including meeting its primary endpoints in a pivotal Phase 3 trial (leronlimab in combination with standard antiretroviral therapies in HIV-infected treatment-experienced patients).
These things are backed by nothing but dust using smoke n mirrors to track the price of crude. Crudes up and uwt down. That means the mirrors have gotten dirty, out of alignment or cracked from too rough handling we saw yesterday. Usually this precedes a reverse split in which they replace any broken mirrors clean the mirrors do a re-alignment and clear out all the smoke.
Thanks for the list I wonder how long before a new 3x long replacement for oilu
Yeah 3x garbage take profits when you have em. I waited till end of day when they take the casino skim always knock a few percent off and I bought it back at .26 plan on selling again tomorrow. NG also fell below $1.61 as low as $1.55 now $1.6. Fear and Panic have a way of dissolving all support levels. So many great trade opportunities in this market.
TOMZ .68 CORONA KILLER! NON-VIDEO CHART NO BULLS VS BEARS BS JUST MONEY TO BE MADE.
TOMZ is building an ascending wedge higher lows relatively flat top low .7s. When a point is formed chart will be ready for a breakout. This is the pt that in tune savy management put out a pr with some meat hanging off of it. From another board
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154417hu853
This would be a huge amount of meat hanging off the pr. I was at Walmart tonight so many items not available. They didnt even have dog or cat food. Starting tomorrow they will close at 8pm and open at 7 or 8am. They said they will be restocking and cleaning disinfecting as necessary. There are no reported cases here, yet. They started a drive thru testing yesterday. Reality is setting in all over. The invisible enemy must be killed. You cant go around wiping everything down. Spraying atomized disinfectant is the best solution. TOMZ has the only EPA approved CORONA KILLING SPRAY. Just like the stuff flying off the shelves TOMZ will be flying soon. GET SUM GET SUM TOMZ CORONA KILLER
TOMZ .68 +10% CORONA KILLER! NON-VIDEO CHART NO BULLS VS BEARS BS JUST MONEY TO BE MADE.
TOMZ is building an ascending wedge higher lows relatively flat top low .7s. When a point is formed chart will be ready for a breakout. This is the pt that in tune savy management put out a pr with some meat hanging off of it. From another board
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=154417hu853
This would be a huge amount of meat hanging off the pr. I was at Walmart tonight so many items not available. They didnt even have dog or cat food. Starting tomorrow they will close at 8pm and open at 7 or 8am. They said they will be restocking and cleaning disinfecting as necessary. There are no reported cases here, yet. They started a drive thru testing yesterday. Reality is setting in all over. The invisible enemy must be killed. You cant go around wiping everything down. Spraying atomized disinfectant is the best solution. TOMZ has the only EPA approved CORONA KILLING SPRAY. Just like the stuff flying off the shelves TOMZ will be flying soon. GET SUM GET SUM TOMZ CORONA KILLER
That is correct ,more importantly AHPI has the smallest float of all Corona stocks 3.37mil no dilution delivering the biggest bang for your Corona bucks.
TOMZ CORONA KILLER working all night after business like walmart close early for daily disinfecting. This is the foreseeable future things will never be the same people will demand daily disinfecting BRIGHT FUTURE FOR TOMZ GET SUM
TOMZ CORONA KILLER Business like Walmart reduces open hours so they can disinfect the entire store nightly. TOMZ working overtime spray schools stores hospitals buses ambulances airlines subways
TXRH $30 just getting warmed up and it pays 1.2 dividend last yr. Great market for traders that can read live chart level II and market indicators.
.30 I'm out quick $5k in about 10mins
.18 low lol when does it go poof! I picked up some .25s for the bounce